Eric Brouwer
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
- Neutropenia and Cancer Infections
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 13
- Cancer Treatment and Pharmacology 6
- Neutropenia and Cancer Infections 4
- Lung Cancer Research Studies 3
- Drug Transport and Resistance Mechanisms 3
-
- Cancer therapeutics and mechanisms 6
- Co-authors
- Alex Sparreboom (12 shared papers)Jaap Verweij (10 shared papers)Walter J. Loos (8 shared papers)Peter de Bruijn (6 shared papers)Kees Nooter (6 shared papers)G. Stoter (6 shared papers)Lia van Zuylen (4 shared papers)Hans Gelderblom (5 shared papers)
- Journals
- Anti-Cancer Drugs (3 papers)Journal of Clinical Oncology (2 papers)Journal of Immunological Methods (2 papers)Drug Metabolism and Disposition (2 papers)Analytical and Bioanalytical Chemistry (1 paper)
- Partner nations
- NetherlandsGermanyUnited States
In The Last Decade
Eric Brouwer
20 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 87
- Oncology 664
- Pharmacology 128
- Biomaterials 144
- Genetics 78
- Pharmaceutical Science 38
Countries citing papers authored by Eric Brouwer
This map shows the geographic impact of Eric Brouwer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Brouwer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Brouwer more than expected).
Fields of papers citing papers by Eric Brouwer
This network shows the impact of papers produced by Eric Brouwer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Brouwer. The network helps show where Eric Brouwer may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Brouwer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications. | 1999 | 277 |
| 2 | 2001 | 109 | |
| 3 | 2005 | 99 | |
| 4 | 2000 | 84 | |
| 5 | Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans. | 2000 | 73 |
| 6 | 2000 | 56 | |
| 7 | 2000 | 52 | |
| 8 | 2000 | 51 | |
| 9 | 2008 | 50 | |
| 10 | 1999 | 32 | |
| 11 | 1998 | 31 | |
| 12 | 2010 | 29 | |
| 13 | 2000 | 25 | |
| 14 | 1999 | 20 | |
| 15 | 2000 | 19 | |
| 16 | 2007 | 19 | |
| 17 | 2012 | 14 | |
| 18 | Locoregional delivery of adenoviral vectors. | 2006 | 7 |
| 19 | 2013 | 6 | |
| 20 | 2019 | 3 |
About Eric Brouwer
Eric Brouwer is a scholar working on Oncology, Molecular Biology, Pharmacology, Neurology and Pharmacology, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Cancer therapeutics and mechanisms (6 papers), Pharmacogenetics and Drug Metabolism (6 papers), Neutropenia and Cancer Infections (4 papers), Lung Cancer Research Studies (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Oncology (664 citations), Pharmacology (128 citations), Biomaterials (144 citations), Genetics (78 citations) and Pharmaceutical Science (38 citations). Eric Brouwer has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Alex Sparreboom, Jaap Verweij, Walter J. Loos, Peter de Bruijn, Kees Nooter, G. Stoter, Lia van Zuylen, Hans Gelderblom, Jaap Verweij and Theo M. Luider. Their work appears in journals such as Anti-Cancer Drugs, Journal of Clinical Oncology, Journal of Immunological Methods, Drug Metabolism and Disposition and Analytical and Bioanalytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.